BBS4

Bardet-Biedl syndrome 4, the group of BBSome|Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 15:72686186-72742006

Links

ENSG00000140463NCBI:585OMIM:600374HGNC:969Uniprot:Q96RK4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Bardet-Biedl syndrome 4 (Definitive), mode of inheritance: AR
  • Bardet-Biedl syndrome 4 (Strong), mode of inheritance: AR
  • Bardet-Biedl syndrome (Supportive), mode of inheritance: AR
  • Bardet-Biedl syndrome 4 (Strong), mode of inheritance: AR
  • ciliopathy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Bardet-Biedl syndrome 4ARCardiovascular; EndocrineIndividuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management; Medical management of obesity with melanocortin-4 receptor (MC4R) agonist (setmelanotide) may be beneficialCardiovascular; Craniofacial; Gastrointestinal; Genitourinary; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic; Renal7711739; 11381270; 12016587; 15654695; 20301537; 22219648; 36356613
Variants may modify the severity of BBS and related disorders due to variants in other BBS-associated genes

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BBS4 gene.

  • Bardet-Biedl syndrome (37 variants)
  • Bardet-Biedl syndrome 4 (8 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BBS4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
130
clinvar
2
clinvar
136
missense
2
clinvar
3
clinvar
160
clinvar
3
clinvar
2
clinvar
170
nonsense
11
clinvar
20
clinvar
1
clinvar
32
start loss
2
clinvar
1
clinvar
3
frameshift
16
clinvar
31
clinvar
4
clinvar
51
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
7
clinvar
21
clinvar
2
clinvar
30
splice region
2
5
13
29
1
50
non coding
3
clinvar
29
clinvar
119
clinvar
19
clinvar
170
Total 36 80 206 253 23

Highest pathogenic variant AF is 0.0000329

Variants in BBS4

This is a list of pathogenic ClinVar variants found in the BBS4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-72686190-C-A not specified • Bardet-Biedl syndrome 4 Benign (Jan 12, 2018)262133
15-72686211-C-A Bardet-Biedl syndrome Benign (Oct 13, 2009)21731
15-72686211-C-T not specified • Bardet-Biedl syndrome 4 Benign (Jan 13, 2018)193472
15-72686214-T-A Bardet-Biedl syndrome 4 Uncertain significance (Jan 13, 2018)317057
15-72686220-G-C BBS4-related disorder Likely benign (Apr 17, 2019)3355988
15-72686222-G-A Bardet-Biedl syndrome Benign (Oct 13, 2009)21733
15-72686225-A-G Bardet-Biedl syndrome 4 Uncertain significance (Jan 06, 2022)595052
15-72686228-A-G Bardet-Biedl syndrome • BBS4-related disorder Pathogenic/Likely pathogenic (Dec 22, 2023)886465
15-72686229-T-C Bardet-Biedl syndrome Pathogenic/Likely pathogenic (Aug 17, 2023)445809
15-72686232-C-T Bardet-Biedl syndrome Uncertain significance (Apr 17, 2022)1375048
15-72686233-T-A Bardet-Biedl syndrome • BBS4-related disorder Likely benign (Nov 27, 2023)1128198
15-72686233-T-G Bardet-Biedl syndrome Likely benign (Feb 21, 2023)2839446
15-72686235-A-C Bardet-Biedl syndrome Benign (Oct 13, 2009)21741
15-72686236-G-A Bardet-Biedl syndrome Likely benign (Dec 05, 2023)2916566
15-72686237-G-A Bardet-Biedl syndrome Uncertain significance (Jul 12, 2022)1377984
15-72686237-G-C Bardet-Biedl syndrome Uncertain significance (Jun 30, 2022)2012196
15-72686237-G-T Bardet-Biedl syndrome • Bardet-Biedl syndrome 4 Pathogenic/Likely pathogenic (Aug 10, 2023)2197130
15-72686239-G-A not specified • Bardet-Biedl syndrome Likely benign (Dec 26, 2023)262138
15-72686241-G-C Bardet-Biedl syndrome Uncertain significance (Apr 26, 2022)1426835
15-72686243-G-A Bardet-Biedl syndrome Uncertain significance (Mar 27, 2022)2118470
15-72686244-T-C Bardet-Biedl syndrome Benign (Oct 13, 2009)21736
15-72686244-T-G BBS4-related disorder Uncertain significance (Sep 05, 2024)3350684
15-72686245-C-A Bardet-Biedl syndrome Likely benign (Jul 29, 2023)2955906
15-72686245-C-T Bardet-Biedl syndrome Benign (Oct 13, 2009)21737
15-72686246-G-A Bardet-Biedl syndrome Uncertain significance (Mar 18, 2022)1474887

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BBS4protein_codingprotein_codingENST00000268057 1652291
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.45e-160.04401256780701257480.000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.9563012581.170.00001283375
Missense in Polyphen7776.6611.00441009
Synonymous-1.2511296.41.160.00000511954
Loss of Function0.7352731.40.8580.00000146398

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005640.000564
Ashkenazi Jewish0.0001980.000198
East Asian0.0001630.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0003090.000308
Middle Eastern0.0001630.000163
South Asian0.0002950.000294
Other0.0008150.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization. Required for microtubule anchoring at the centrosome but not for microtubule nucleation. May be required for the dynein-mediated transport of pericentriolar proteins to the centrosome. {ECO:0000269|PubMed:15107855, ECO:0000269|PubMed:17574030, ECO:0000269|PubMed:22072986}.;
Pathway
Prader-Willi and Angelman Syndrome;BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.328

Intolerance Scores

loftool
0.571
rvis_EVS
0.11
rvis_percentile_EVS
62.1

Haploinsufficiency Scores

pHI
0.129
hipred
N
hipred_score
0.415
ghis
0.513

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.921

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Bbs4
Phenotype
taste/olfaction phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; pigmentation phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; renal/urinary system phenotype;

Zebrafish Information Network

Gene name
bbs4
Affected structure
pancreatic B cell
Phenotype tag
abnormal
Phenotype quality
increased area

Gene ontology

Biological process
microtubule cytoskeleton organization;mitotic cytokinesis;neuron migration;neural tube closure;retina homeostasis;heart looping;negative regulation of systemic arterial blood pressure;centrosome cycle;spermatid development;visual perception;sensory perception of smell;negative regulation of gene expression;protein transport;dendrite development;regulation of lipid metabolic process;ventricular system development;striatum development;hippocampus development;cerebral cortex development;adult behavior;negative regulation of actin filament polymerization;melanosome transport;regulation of cytokinesis;protein localization to organelle;negative regulation of GTPase activity;microtubule anchoring at centrosome;social behavior;photoreceptor cell outer segment organization;negative regulation of appetite by leptin-mediated signaling pathway;positive regulation of multicellular organism growth;fat cell differentiation;photoreceptor cell maintenance;positive regulation of cilium assembly;retinal rod cell development;intracellular transport;brain morphogenesis;sensory processing;maintenance of protein location in nucleus;regulation of stress fiber assembly;cilium assembly;regulation of cilium beat frequency involved in ciliary motility;face development;fat pad development;protein localization to cilium;protein localization to centrosome;regulation of non-motile cilium assembly;protein localization to photoreceptor outer segment;non-motile cilium assembly
Cellular component
pericentriolar material;photoreceptor outer segment;photoreceptor inner segment;nucleus;centrosome;centriole;cytosol;cilium;motile cilium;photoreceptor connecting cilium;centriolar satellite;BBSome;ciliary transition zone;ciliary basal body;ciliary membrane;non-motile cilium
Molecular function
RNA polymerase II repressing transcription factor binding;microtubule motor activity;protein binding;dynactin binding;alpha-tubulin binding;beta-tubulin binding